Thank you for Subscribing to CIO Applications Weekly Brief
EVERSANA announces strategic partnership with Roivant Sciences to advance commercialization services and predictive analytics for healthcare
CIO Applications| Monday, November 16, 2020
CHICAGO, BASEL, and NEW YORK – Roivant Sciences today namedEVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, a preferred provider of commercial services worldwide. Under the agreement, EVERSANA and Roivant will partner on opportunities to improve the access, affordability and adherence of innovative therapies developed by Roivant.In addition, EVERSANA and Roivant will expand existing partnerships around multiple Roivant technology platforms, including deploying Alyvant’s salesforce app to enhance results for EVERSANA clients.
Jim Lang, CEO
Roivant has a diverse pipeline of investigational drugs acrossits family of companies.In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused platforms aimed at improving the process of developing and commercializing medicines.
EVERSANA, which is currently managing the launch of multiple pharmaceutical and digital therapies, offers a fully integrated commercial services platform designed to solve global pricing, access, reimbursement, real-world evidence, adherence and product delivery challenges in the life sciences sector.
“We are thrilled to collaborate withEVERSANA on deploying innovative technologies and nontraditional approaches to improve the delivery of medicines to patients –within and beyond our own pharmaceutical portfolio,” said Ben Zimmer, President of Roivant Health.
“Roivant shares our view that traditional approaches to commercialization services leave too much value on the table. Ourpatients, providers and payers need a more comprehensive approach to life sciences services, propelled by bolder strategies and integrated superior performance that is optimized by apredictive platform of data and analytics at each step of the patient and product journeys,” said Jim Lang, CEO, EVERSANA.